Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1373597Generated: October 26, 2026

Triethylamine → 7-[4-(4-Naphthalen-1-yl-piperazin-1-yl)-butoxy]-3-(2,2,2-trifluoro-ethyl)-1h-[1,8]naphthyridin-2-one

https://huagongshe.com/reaction/1373597

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTriethylamineHCID 8471—
ReactantSodium ThiosulfateHCID 24477—
ReactantTriacetoxyperiodinaneHCID 159087—
Reactant1-(1-Naphthyl)piperazine hydrochlorideHCID 2737391—
ReactantSodium triacetoxyborohydrideHCID 5049666—
Reactant7-(4-Hydroxy-butoxy)-3-(2,2,2-trifluoro-ethyl)-1h-[1,8]naphthyridin-2-oneHCID 21073842—
Solvent1,2-DichloroethaneHCID 11—
SolventDiethyl EtherHCID 3283—
SolventDichloromethaneHCID 6344—
SolventTetrahydrofuranHCID 8028—
Product7-[4-(4-Naphthalen-1-yl-piperazin-1-yl)-butoxy]-3-(2,2,2-trifluoro-ethyl)-1h-[1,8]naphthyridin-2-oneHCID 2107381150%

Reaction Steps

To a suspension of Dess-Martin periodinane (0.419 g, 0.99 mmol, 1.2 eq) in CH2Cl2 (20 mL) was added a solution of 7-(4-hydroxy-butoxy)-3-(2,2,2-trifluoro-ethyl)-1H-[1,8]naphthyridin-2-one (0.26 g, 0.82 mmol) in THF (8 mL). The mixture was stirred at room temperature for 1 h. Et2O (100 mL) was added to dilute the reaction mixture. The reaction was quenched with aqueous NaHCO3 (20 mL) containing Na2S2O3 (0.91 g, 5.74 mmol, 7 eq). After extraction with Et2O (3×50 mL), the combined organic layer was washed with brine (20 mL), dried over Na2SO4, and concentrated to give the crude aldehyde as a pale yellow solid. To a solution of the crude aldehyde in 1,2-dichloroethane (20 mL) was added 1-naphthalen-1-yl-piperazine monohydrochloride (0.286 g, 1.15 mmol, 1.4 eq), Et3N (0.21 mL, 1.56 mmol, 1.9 eq) and NaBH(OAc)3 (0.241 g, 1.15 mmol, 1.4 eq). The mixture was stirred at room temperature for 1 h. The reaction was quenched with water and saturated NaHCO3. After extraction with CH2Cl2 (3×50 mL), the combined organic layer was dried over Na2SO4 and concentrated. The residue was purified by column chromatography (2% MeOH/CH2Cl2) to give the title compound (200 mg, 50% in two steps). 1H NMR (400 MHz, δ ppm): 9.05 (br s, 1H), 8.20 (d, J=6.2 Hz, 1H), 7.80 (d, J=6.0 Hz, 1H), 7.75 (m, 2H), 7.58 (d, J=6.3 Hz, 1H), 7.50 (m, 2H), 7.40 (t, J=6.3 Hz, 1H), 7.10 (d, J=5.3 Hz, 1H), 6.40 (d, J=6.5 Hz, 1H), 4.40 (t, J=4.2 Hz, 2H), 3.50 (q, J=7.5 Hz, 2H), 3.20 (br s, 4H), 2.80 (br s, 4H), 2.60 (m, 2H), 1.90 (m, 2H), 1.72 (m, 2H). 19F NMR: −65.6 ppm. MS: 511 (M+). Elemental Analysis calculated for C28H29F3N4O2: C, 65.88; H, 5.69; N, 10.98. Found: C, 66.08; H, 5.89; N, 10.67.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07160888B2
Source datasetuspto-grants-2007_01
ORD IDord-ae36eadb1ff84ed0ae33213fc3b4efe5
Source noteuspto-grants-2007_01